CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

The Importance of Medical Writing in Emerging Healthcare Landscape

The Importance of Medical Writing in...

Life Science Sector All Set to Soar Via a Technology-driven Approach

Life Science Sector All Set to Soar...

A Convergence-deemed Capital To Accelerate the Marketing Insights of the Life Science Sector

A Convergence-deemed Capital To...

The Future of Life Sciences Regulation

The Future of Life Sciences Regulation

Prognosis for Life Science Regulation

Prognosis for Life Science Regulation

Major Compliance Challenges Facing The Life Science Industry In 2022

Major Compliance Challenges Facing...

How Pharmaceutical Automation is Revolutionizing Drug Development

How Pharmaceutical Automation is...

Major Challenges In The Evolving Era Of Life Sciences

Major Challenges In The Evolving Era...

The Importance of Medical Writing in Emerging Healthcare Landscape

The Importance of Medical Writing in...

Life Science Sector All Set to Soar Via a Technology-driven Approach

Life Science Sector All Set to Soar...

A Convergence-deemed Capital To Accelerate the Marketing Insights of the Life Science Sector

A Convergence-deemed Capital To...

The Future of Life Sciences Regulation

The Future of Life Sciences Regulation

Prognosis for Life Science Regulation

Prognosis for Life Science Regulation

Major Compliance Challenges Facing The Life Science Industry In 2022

Major Compliance Challenges Facing...

How Pharmaceutical Automation is Revolutionizing Drug Development

How Pharmaceutical Automation is...

Major Challenges In The Evolving Era Of Life Sciences

Major Challenges In The Evolving Era...

Compliance in the Life Sciences Sector

Life Sciences Review | Wednesday, February 03, 2021
Tweet

It will benefit the life science compliance team if they collaborate with trusted partners to reduce risk. 


FREMONT, CA: There are several issues specific to the field because any compliance professional employed in life sciences recognizes them. It is a highly regulated industry, and compliance programs in the life sciences often become complicated, involving multiple jurisdictions addressing extended supply chains and numerous third parties. Life sciences compliance has been put under scrutiny to look at challenges presently the industry is dealing with, how to solve them, and what is there in the future.


Unavoidable Compliance Risks


When it comes to bribery and corruption, the life sciences industry does not have a decent reputation. It is estimated that more than US$7 trillion is spent on health care worldwide, according to The Lancet, but at least 10-25 percent of this global investment is wasted directly through corruption.


The stakeholders' structure is a primary explanation for this, with many companies directly partnering with hospitals or other government-owned entities. Strong dependency on sales teams and third-party agents or finders to attract government customers reveals an apparent vulnerability to public corruption. As a result, businesses, powered by local customs and regulations, are subject to many enforcement problems, which may include:


• Management of gifts and entertainment


• Exposure to government interference


• A common use of kickbacks in the sales process


• Engagement with politically exposed persons


• Complex supply chains


See Also: Top Pharma and Life Sciences Analytics Consulting Companies


Many compliance programs for life sciences are costly and unwieldy. Some work in silos or are isolated, missing an enterprise-wide view of the problems they face in compliance. In addition to this tension between the management of regulatory risk and the achievement of business objectives, it is obvious why issues occur.


Rising to the Challenge: Next-Gen Compliance


To prevent a regulatory fall-out, it is essential for life sciences companies build a comprehensive enforcement strategy enterprise-wide. In enabling this to happen, the enhancement of enforcement and risk management systems through the implementation of technology frameworks would play a key role. Compliance anomalies would be easier to detect and fix as compliance procedures become more automated.


For example, using a compliance platform for third-party management that continuously reviews each third-party relationship's status would detect problems before they trigger concern. By integrating upfront and annual enforcement training for both workers and third parties, such a platform could serve a dual purpose. In a post-merger situation, introducing AI-based technologies to support high volume diligence remediation services may also help define FCPA's successor responsibility in inherited transactions.


Compliance teams in the life sciences will benefit from partnering to support successful risk reduction initiatives with a trusted partner. They have extensive experience at IntegrityRisk, helping clients manage a broad range of risks to produce positive results.


Weekly Brief

loading
Top 10 Life Sciences Compliance Solutions Companies - 2022
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/compliance-in-the-life-sciences-sector-nwid-245.html